"Dr. Ayman El-Shibiny is currently a professor of biomedical sciences at the University of Science and Technology, Zewail City. Prior to joining Zewail City, El-Shibiny worked as a postdoctoral fellow at a number of universities including Nottingham University in the U.K., Cardiff University in the U.K., and The Evergreen State College in the U.S. He also served as an associate professor and head of the food sciences department at the Faculty of Environmental Agricultural Sciences, Suez Canal University (Egypt). El-Shibiny started his academic career by graduating from Egypt’s Suez Canal University with a Bachelor of Science degree in environmental and agricultural sciences in 1992 and he obtained his Master of Science degree in food sciences from the same university in 1998. He then completed his Doctor of Philosophy degree in microbiology from The University of Nottingham, UK. As a microbiologist, El-Shibiny’s research interests cover a broad range of topics related to food safety and human health. His main research area is phage therapy and his current research interests include the therapeutic use of bacteriophages as a possible alternative to treat and control antibiotic-resistant pathogens. His research has aimed at improving our understanding of the causes of contamination of foods of animal origin with human pathogens. El-Shibiny has a strong scientific network in the U.K., the U.S., Belgium, Canada, France and Egypt. His last project at The Evergreen State College was supported by the U.S. National Institute of Health to study various aspects of Escherichia coli infection, including E. coli 0157 and phage therapy. El-Shibiny is a member of various scientific societies including the American Society for Microbiology, the Society for General Microbiology, the Egyptian Society of Food Science and Technology, and the Egyptian Society of Applied Sciences."

As a microbiologist, El-Shibiny’s research interests cover a broad range of topics related to food safety and human health. His main research area is phage therapy and his current research interests include the therapeutic use of bacteriophages as a possible alternative to treat and control antibiotic-resistant pathogens. His research has aimed at improving our understanding of the causes of contamination of foods of animal origin with human pathogens.